Last updated:
Filter results
You can narrow down the results using the filters
Publication type
Topic
Disease
565 results
Search results
-
SSBA – Guideline 9 – Non-registered facility report and requirements
This guideline outlines the reporting and other general requirements for a non-registered facility that receives a confirmed, or suspected, security sensitive biological agent (SSBA). -
SSBA – Guideline 10 – Monitoring inspections
This guideline lets facilities know what to expect when scheduled for a monitoring inspection. It includes details about required pre-inspection actions, the inspection process itself, and potential post-inspection actions. -
SSBA – Guideline 11 – SSBAs and other regulatory schemes
This guideline informs entities and facilities under the Security Sensitive Biological Agents (SSBA) Regulatory Scheme when and how they can allow other regulatory schemes to access secure SSBA areas or sensitive information. -
SSBA – Internal review tool
This tool helps entities and facilities that handle security sensitive biological agents (SSBAs) to check their compliance with the SSBA Standards. Use of this tool is not mandatory. -
SSBA – Security Risk Assessment and Risk Management Plan template
Facilities that handle security sensitive biological agents (SSBAs) can use this template to help them make sure they identify and manage all risks associated with handing SSBAs. Use of the template is not mandatory. -
Climate and Health Expert Advisory Group (CHEAG) communique – 12 December 2025
The Climate and Health Expert Advisory Group met on 12 December 2025. This document provides a record of the meeting. -
National Arbovirus and Malaria Advisory Committee (NAMAC) – Charter
This document contains the NAMAC Charter. -
Australian Respiratory Surveillance Report – 1 to 28 December 2025
This Australian Respiratory Surveillance Report (ARSR) includes information about acute respiratory illnesses including COVID-19, influenza and respiratory syncytial virus. -
Public interest disclosure procedures
This document contains our procedures for facilitating and dealing with public interest disclosures relating to the Australian Centre for Disease Control. -
Leptospirosis – Surveillance case definition
This document contains the surveillance case definition for leptospirosis, which is nationally notifiable within Australia. State and territory health departments use this definition to decide whether to notify us of a case. -
Hepatitis A – Surveillance case definition
This document contains the surveillance case definition for hepatitis A, which is nationally notifiable within Australia. State and territory health departments use this definition to decide whether to notify us of a case. -
Privacy policy
Our privacy policy sets out how we comply with the Privacy Act 1988. -
Public interest disclosures – Australian Privacy Principles 5 collection notice
This document outlines how we handle your personal information if you make a public interest disclosure. -
Information Publication Scheme Agency Plan 2026 to 2028
This plan outlines the processes we follow and the steps involved in managing our information and making it available online. -
National Occupational Respiratory Disease Registry Annual Report 2024–25
This report covers data captured in the National Registry between 22 May 2024 and 30 June 2025. -
Chlamydial infection – Surveillance case definition
This document contains the surveillance case definition for chlamydial infection, which is nationally notifiable within Australia. State and territory health departments use this definition to decide whether to notify us of a case. -
Mpox treatment guidelines
Guidelines for health professionals that outline the therapeutic options for the management of mpox and vaccine related complications. -
Mpox – CDNA National Guidelines for Public Health Units
These guidelines describe recommended public health responses to cases and contacts of mpox. The Communicable Diseases Network Australia (CDNA) will continue to review these guidelines as more information becomes available. -
Melioidosis – Laboratory case definition
The Public Health Laboratory Network (PHLN) has developed standard case definitions for the diagnosis of key diseases in Australia. This document contains the laboratory case definition for melioidosis. -
National Syphilis Surveillance Report Q2 2025
The National Syphilis Surveillance Reports are part of a collection that report progress against the National Syphilis Surveillance and Monitoring Plan 2025. -
National Notifiable Diseases Surveillance System (NNDSS) fortnightly reports – 10 to 23 November 2025
This report and accompanying table provide a fortnightly summary on notifications of Australia's nationally notifiable diseases for 10 to 23 November 2025. -
معلومات للمرضى
إذا تم تشخيصك بمرض تنفسي مهني، فقد يقوم طبيبك بإبلاغ معلوماتك إلى السجل. اعرف متى يجب على طبيبك تقديم تقرير إلى السجل وما هي المعلومات التي تحتاج إلى تقديمها -
Informazioni per i pazienti
Se hai ricevuto una diagnosi di malattia respiratoria professionale, il tuo medico potrebbe trasmettere le tue informazioni al Registro. Fatti dire quando il tuo medico deve informare il Registro e che tipo di informazione devi fornire. -
बिरामीहरूका लागि जानकारी
यदि तपाईंलाई व्यावसायिक श्वासप्रश्वास सम्बन्धी रोग भएको निदान गरिन्छ भने, तपाईंको चिकित्सकले तपाईंको जानकारी दर्ता प्रणालीमा रिपोर्ट गर्न सक्छन्। तपाईंको चिकित्सकले कहिले दर्ता प्रणालीमा रिपोर्ट गर्नुपर्छ र तपाईंले कस्तो जानकारी प्रदान गर्नुपर्छ भनेर पत्ता लगाउनुहोस्। -
ਮਰੀਜ਼ਾਂ ਵਾਸਤੇ ਜਾਣਕਾਰੀ
ਜੇ ਤੁਹਾਡੇ ਵਿੱਚ ਕਿਸੇ ਕਿੱਤਾਕਾਰੀ ਸਾਹ ਦੀ ਬਿਮਾਰੀ ਦੀ ਪਛਾਣ ਕੀਤੀ ਜਾਂਦੀ ਹੈ, ਤਾਂ ਤੁਹਾਡਾ ਡਾਕਟਰ ਤੁਹਾਡੀ ਜਾਣਕਾਰੀ ਦੀ ਰਿਪੋਰਟ ਰਜਿਸਟਰੀ ਨੂੰ ਕਰ ਸਕਦਾ ਹੈ। ਪਤਾ ਕਰੋ ਕਿ ਤੁਹਾਡੇ ਡਾਕਟਰ ਨੂੰ ਰਜਿਸਟਰੀ ਨੂੰ ਕਦੋਂ ਰਿਪੋਰਟ ਕਰਨੀ ਚਾਹੀਦੀ ਹੈ ਅਤੇ ਤੁਹਾਨੂੰ ਕਿਹੜੀ ਜਾਣਕਾਰੀ ਪ੍ਰਦਾਨ ਕਰਨ ਦੀ ਲੋੜ ਹੈ।